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ABSTRACT
ObjectiveToevaluaterestingheartrateasanindependent
predictor of cardiovascular risk in women.
Design Prospective cohort study.
Setting The Women’s Health Initiative was undertaken at
40 research clinics in the United States.
Participants 129135 postmenopausal women.
Main outcome measure Clinical cardiovascular events.
Results During a mean of 7.8 (SD 1.6) years of follow up,
2281womenwereidentifiedwithmyocardialinfarctionor
coronary death and 1877 with stroke. We evaluated
associations between resting heart rate and
cardiovascular events in Cox regression models adjusted
for multiple covariates. Higher resting heart rate was
independently associated with coronary events (hazard
ratio 1.26, 95% confidence interval 1.11 to 1.42 for
highest[>76beatsperminute]vlowestquintile[≤62beats
per minute]; P=0.001), but not with stroke. The relation
between heart rate and coronary events did not differ
between white women and women from other ethnic
groups (P for interaction=0.45) or between women with
and without diabetes (P for interaction=0.31), but it was
stronger in women aged 50-64 at baseline than in those
aged 65-79 (P for interaction=0.009).
ConclusionRestingheartrate,alowtechandinexpensive
measure of autonomic tone, independently predicts
myocardialinfarctionorcoronarydeath,butnotstroke,in
women.
Trial registration ClinicalTrials.gov NCT00000611.
INTRODUCTION
Resting heart rate, an indicator of autonomic nervous
systemtone,independentlypredictscoronaryeventsin
men.
1-4 Evidence to date suggests that this relation is
weaker or absent in women
235-8 except for one study
that showed a strong association of heart rate with
cardiovascular death in African-American women in
the National Health And Nutrition Examination
Survey.
9 The relation between heart rate and stroke
in women is also unclear.
High sympathetic tone might serve as a marker of
subclinical cardiovascular disease, or could adversely
affect known risk factors such as blood pressure,
glucose metabolism, and plasma lipids.
3 Depression
and anxiety have been associated with autonomic
dysfunction
1011 and coronary events,
12 but have infre-
quently been included in analyses of heart rate and
cardiovascular risk.
We assessed resting heart rate as an independent
predictor of myocardial infarction or coronary death
and stroke in a large cohort of women with a broad
range of cardiovascular risk, and compared the
strength of these associations by age and ethnic group.
METHODS
Study population
The Women’s Health Initiative includes 161808
postmenopausal women enrolled at 40 clinical sites
into four randomised trials and an observational study
from 1993 to 1998.
13 The present analysis included
participants from the observational study and women
from the intervention and control groups in the
randomised trials. We excluded women with previous
myocardial infarction, stroke, or coronary revascular-
isationat baseline,andthose reportingcurrentuseof β
blockers, digoxin, or non-dihydropyridine calcium
channel blockers at baseline, since these agents might
affect heart rate. Accordingly the analysis included
129135 women. The study population and collection
of baseline data have been described previously.
14-16
Measurement of heart rate and covariates
At baseline, women sat quietly for 5 minutes before a
trained observer measured heart rate by palpating the
radialpulsefor30seconds.Weselectedcovariatesthat
might be expected to affect heart rate, coronary heart
disease, or risk of stroke. Hypertension, smoking,
consumptionof caffeine and alcohol, diabetesmellitus
requiringdietaryordrugtherapy,andhighcholesterol
requiring drug treatment were assessed by self-
reportedquestionnaireatbaseline.Plasmalipoproteins
and glucose were not measured in most women;
consequently, hypercholesterolaemia and diabetes
were defined exclusively by self-report. Women
broughttheirmedicationstoclinicvisitsforinventory.
Total physical activity was assessed by questions on a
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BMJ | ONLINE FIRST | bmj.com page 1 of 6frequency and duration scale for walking and other
types of activity.
17 Depression was assessed using six
items from the Center for Epidemiological Studies
depression scale.
18 Anxiety was assessed by asking
“Haveyoubeenaverynervousperson?”withresponse
categories“allofthetime”,“mostofthetime”,“agood
bit of the time”, “some of the time”, “a little bit of the
time”, and “none of the time.” We combined the first
four categories for analyses, because the first three
categories encompassed less than 8% of women.
Hormone use reflected blinded treatment assignment
in the randomised trials and open label use of
oestrogen.
Ascertainment of outcomes
Participants reported emergency room visits, over-
night stays in hospital, and outpatient coronary
revascularisation procedures every 6 months.Medical
records for all deaths, overnight hospital stays, and
outpatientcoronaryrevascularisationprocedureswere
scrutinisedforpotentialoutcomesofinterest.Centrally
trained physician adjudicators classified outcomes by
reviewing medical records. Myocardial infarction was
categorised using an algorithm that included symp-
toms, electrocardiographic findings, and cardiac
enzyme measurements.
19 Stroke was defined as rapid
onset of a persistent neurological deficit not caused by
trauma, tumour, infection, or other cause.
20
Statistical analysis
Wedividedrestingheartrateintoquintilesordeciles.For
continuousmarkers,weevaluateddifferencesinbaseline
characteristicsbymodellingthecovariateofinterestbya
continuous term of heart rate category in a linear model.
Categorical models were evaluated using a χ
2 test
comparing the marker of interest and the categories of
heart rate. For multivariable analysis, we calculated
hazard ratios with 95% confidence intervals from Cox
regressionmodelsadjustedforallthecovariatesshownin
the tables; age, body mass index, caffeine, and saturated
fat consumption were included as continuous variables.
Weassessedinteractionsbetweenheartrateorchangein
heart rate quintile and coronary heart disease or risk of
stroke by age, ethnic origin, and presence of diabetes
mellitus at baseline; P values were calculated from
likelihood ratio tests by comparing models with and
Table 1 |Characteristics of study population by quintile of resting heart rate at baseline
≤62 bpm
(n=32195)
63-66 bpm
(n=23213)
67-70 bpm
(n=24235)
71-76 bpm
(n=25453)
>76 bpm
(n=24039)
P
value
Age, years 62.4 (7.2) 62.6 (7.2) 62.7 (7.2) 62.8 (7.2) 63.0 (7.1) <0.001
Ethnic origin, % ————— <0.001
White 84 83 84 84 83 —
Black 7 7 7 8 10 —
Hispanic 5 5 4 4 4 —
American Indian 0.4 0.4 0.5 0.4 0.4 —
Asian/Pacific Islander 3 3 3 2 2 —
Unknown 1 1 1 1 1 —
Hypertension, % 25 27 28 31 36 <0.001
Diabetes mellitus ever, % 3 3 4 5 8 <0.001
Current smoking, % 6 6 7 8 9 <0.001
High cholesterol requiring drugs, % 9 10 11 11 12 <0.001
Depressive symptoms score, points 2.2 (2.5) 2.2 (2.5) 2.3 (2.5) 2.3 (2.6) 2.5 (2.6) <0.001
Nervousness, % ————— <0.001
At least some of the time 19 20 20 20 22 —
A little bit of the time 35 35 35 35 35 —
None of the time 46 45 45 44 43 —
Body mass index, kg/m
2 27 (5) 27 (5) 28 (6) 28 (6) 29 (6) <0.001
Physical activity, metabolic
equivalent-h/week
16 (16) 13 (14) 13 (14) 12 (13) 11 (12) <0.001
Alcohol use ————— <0.001
Current 73.6 72.5 72.8 71.2 68.8 —
Past 15.7 16.4 16.3 17.6 19.4 —
Never 9.9 10.4 10.3 10.5 11.0 —
Dietary caffeine, mg/day 170 (135) 171 (136) 173 (137) 173 (135) 171 (136) 0.22
Dietary % energy from saturated fat 10.5 (3.3) 10.8 (3.3) 10.9 (3.3) 11.1 (3.3) 11.3 (3.3) <0.001
Hormone use at baseline ————— <0.001
None 59 60 62 63 66 —
Unopposed oestrogen 23 21 20 19 17 —
Oestrogen with progestogen 19 19 18 17 17 —
Statin use, % 4.7 5.2 5.4 5.6 6.2 <0.001
bpm=beats per minute.Values are mean (SD) or percentage. Diabetes mellitus ever excludes gestational diabetes.
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two-sided.Analysesweredonebythestatisticsunitatthe
FredHutchinsonCancerResearchCenterusingtheSAS
SystemforWindowsversion9(SASInstitute,Cary,NC).
RESULTS
Duringameanof7.8(SD1.6)yearsoffollow-up,2281
coronary events (myocardial infarction or coronary
death)and1877strokeswereidentifiedamong129135
postmenopausal women who at baseline did not have
cardiovascular disease and were not taking bradycar-
diogenic drugs. Table 1 shows baseline characteristics
by quintile of resting heart rate. In general, age, body
massindex,andsaturatedfatconsumptionwerehigher
and cardiovascular risk factors such as hypertension,
diabetes, smoking, hypercholesterolaemia, and
depressive symptoms more prevalent in women with
higher resting heart rate, as was self reported nervous-
ness. Physical activity and alcohol use were inversely
relatedtoheartrate(both P<0.001),andheartratewas
lower in women who used postmenopausal hormone
therapy than in those who did not (P<0.001).
In univariate analysis, resting heart rate predicted
myocardialinfarctionorcoronarydeath,withahazard
ratio of 1.68 (95% confidence interval 1.49 to 1.89) for
the highest (>76 beats per minute) versus lowest (≤62
beats per minute) quintile (p<0.001; table 2). In
multivariable analysis, higher resting heart rate was
independentlyassociatedwithincreasedcoronaryrisk,
with a hazard ratio of 1.26 (95% confidence interval
1.11 to 1.42) for the highest versus lowest quintile
(P=0.001). For the highest (>80 beats per minute)
versus lowest decile (≤60 beats per minute) of resting
heart rate, the hazard ratio was 1.33 (95% confidence
interval 1.14 to 1.55; P=0.002; data not shown).
In univariate analysis, resting heart rate also
predicted stroke (table 2), with hazard ratio 1.23
(95% confidence interval 1.07 to 1.41) for the highest
versus lowest quintile (P=0.007). In multivariable
analysis, however, heart rate was not independently
associated with stroke (P=0.64; table 3). When the
multivariable analysis was limited to ischaemic stroke
(n=1084), hazard ratios with 95% confidence intervals
for heart rate quintiles were 1.00, 1.22 (1.00 to 1.49),
1.16(0.96to1.41),1.16(0.96to1.40),and1.24(1.02to
1.50), with a P value of 0.197. When the analysis was
limited to haemorrhagic stroke (n=366), hazard ratios
with 95% confidence intervals for heart rate quintiles
were 1.00, 1.06 (0.75 to 1.49), 1.09 (0.76 to 1.56), 1.14
(0.82 to 1.59) and 0.94 (0.65 to 1.35), with a P value of
0.849.
Coronary events and stroke were independently
associated with age, hypertension, diabetes, smoking,
and consumption of saturated fat (table 3). Greater
physical activity and consumption of alcohol and
caffeine were associated with lower risk of coronary
events, but not with stroke. Black and Asian ethnic
origins were associated with lower risk of coronary
eventsthanotherethnicgroups;Hispanicethnicorigin
was associated with lower risk of coronary events and
stroke. Use of oestrogen with progestogen was
associated with a reduced risk of coronary events and
stroke, compared with no oestrogen use, whereas
unopposed oestrogen use was associated with a lower
risk of coronary events and higher risk of stroke.
In formal interaction testing, we found that the
relationbetweenrestingheartrateandcoronaryevents
orstrokedidnotdifferbetweenwhitewomenandthose
from other ethnic groups (P for interaction=0.45 for
coronary events and 0.85 for stroke), and between
women with and without diabetes mellitus at baseline
(Pforinteraction=0.31forcoronaryeventsand0.92for
stroke). The relation with resting heart rate differed by
age for coronary events (P for interaction=0.009;
table 4). The association of higher heart rate with
coronary events was stronger in women aged
50-64 years than in those aged 65-79 years at baseline.
We noted no such interaction between heart rate and
age for stroke (P for interaction=0.14).
DISCUSSION
Principal findings
In a large, diverse cohort of postmenopausal women,
resting heart rate was an independent predictor of
coronaryevents,withhigherheartrateassociatedwith
greaterrisk.Therelationbetweenrestingheartrateand
risk of coronary events was stronger in younger
postmenopausal women than in older ones. Resting
heart rate did not independently predict stroke.
Strengths and limitations
Strengths of this analysis include the size and diversity of
the cohort, the use of prospective ascertainment and
adjudication of outcomes, the large number of clinical
events, and the range of covariates available for analysis,
includingphysicalactivityanddepression.Alimitationis
that since electrocardiograms were not done for most of
the participants, they were not used for this analysis;
consequently,somewomenincludedintheanalysismay
havehadatrialfibrillationorpermanentpacemakers.We
excluded individuals taking digoxin, β blockers, and
calcium channel blockers, which should have covered
most womenwithatrialfibrillation. Another limitationis
thatthe cohort includedno womenyounger than 50 and
no men.
Relation to other studies
The association of depression with coronary heart
disease has been attributed to behaviours induced by
Table 2 |Resting heart rate by quintile as a predictor of coronary events and stroke in
univariable analysis
Myocardial infarction or coronary death Stroke
≤62 bpm (referent) 1.00 1.00
63-66 bpm 1.07 (0.94 to 1.23) 1.07 (0.93 to 1.24)
67-70 bpm 1.19 (1.04 to 1.36) 1.02 (0.88 to 1.18)
71-76 bpm 1.21 (1.06 to 1.38) 1.21 (1.06 to 1.38)
>76 bpm 1.68 (1.49 to 1.89) 1.23 (1.07 to 1.41)
P value <0.001 0.07
bpm=beats per minute. Values are hazard ratio (95% CI) unless otherwise indicated. Stratified for participation
in hormone trial, dietary modification trial, and observational study.
RESEARCH
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and its physiological consequences, including adverse
effectsoninflammationandonendothelialandplatelet
function.
11182122 Depression has been associated with
autonomic dysregulation, leading to increased heart
rate and reduced heart rate variability.
2324 In our
analysis, depressive symptoms were not associated
with coronary events or stroke with or without
adjustment for heart rate (data not shown), so we are
unableto confirmthat the relationbetweendepressive
symptoms and clinical events is mediated through
autonomiceffects.Thislimitationmightbeattributable
to the fact that this subsample of the Women’s Health
Initiative cohort had quite low scores for depressive
symptoms—that is, was not very depressed.
Heart rate was higher in women with self reported
nervousness than in less nervous women, but
nervousness was not independently associated with
either coronary events or stroke in our analysis. This
finding contrasts with reports identifying anxiety as a
predictor of coronary events or of poor outcome after
coronary artery bypass surgery.
2122 Possible explana-
tions are that our dataset did not include a true anxiety
scale,orthatadjustmentforheartrateandseveralother
variables weakened the association of coronary events
withanxiety.Thelatterexplanationmightalsoaccount
for the absence of an association between alcohol
consumptionandcoronaryeventsinthe multivariable
analysis.
We know from the Women’s Health Initiative
randomised hormone trials that unopposed oestrogen
and oestrogen with progestogen are associated with
increased risk of stroke, and that oestrogen with
progestogen increases coronary events.
202526
Table 3 |Resting heart rate as an independent predictor of coronary events and stroke in multivariable analysis
Myocardialinfarctionorcoronarydeath Stroke
Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
Resting heart rate, beats per minute — 0.001 — 0.64
≤62 (referent) 1.00 1.00 —
63-66 1.02 (0.89 to 1.17) 1.04 (0.90 to 1.20) —
67-70 1.08 (0.95 to 1.23) 0.96 (0.83 to 1.11) —
71-76 1.02 (0.89 to 1.16) 1.07 (0.94 to 1.23) —
>76 1.26 (1.11 to 1.42) 1.01 (0.87 to 1.16) —
Age, per 5 year increase 1.53 (1.48 to 1.58) <0.001 1.69 (1.63 to 1.76) <0.001
Ethnic origin — <0.001 — 0.02
White (referent) 1.00 — 1.00 —
Black 0.68 (0.57 to 0.80) — 1.18 (1.00 to 1.40) —
Hispanic 0.54 (0.40 to 0.74) — 0.71 (0.51 to 0.99) —
American Indian/Alaskan native 1.11 (0.63 to 1.96) — 0.56 (0.21 to 1.48) —
Asian/Pacific Islander 0.60 (0.43 to 0.85) — 0.94 (0.70 to 1.27) —
Unknown 0.91 (0.64 to 1.31) — 1.36 (0.98 to 1.91) —
Hypertension 1.69 (1.55 to 1.84) <0.001 1.87 (1.70 to 2.06) <0.001
Diabetes mellitus ever 2.68 (2.36 to 3.03) <0.001 1.94 (1.66 to 2.27) <0.001
Current smoking 2.32 (2.03 to 2.65) <0.001 1.95 (1.67 to 2.28) <0.001
High cholesterol requiring drugs 1.14 (0.98 to 1.33) 0.057 1.18 (1.00 to 1.40) 0.15
Depression construct >5 1.08 (0.94 to 1.24) 0.29 1.14 (0.98 to 1.33) 0.09
Nervousness — 0.09 — 0.67
None of the time (referent) 1.00 — 1.00 —
A little bit of the time 1.09 (0.99 to 1.20) — 0.96 (0.86 to 1.06) —
At least some of the time 1.12 (1.00 to 1.25) — 1.00 (0.89 to 1.14) —
Body mass index, per 5 kg/m
2 increase 1.08 (1.04 to 1.12) <0.001 1.00 (0.96 to 1.05) 0.98
Physical activity, per 5 metabolic
equivalent-h/week increase
0.97 (0.95 to 0.99) <0.001 0.98 (0.97 to 1.00) 0.08
Alcohol use — 0.007 — 0.21
Never (referent) 1.00 — 1.00 —
Past 1.07 (0.92 to 1.24) — 1.02 (0.86 to 1.20) —
Current 0.91 (0.79 to 1.04) — 0.92 (0.80 to 1.07) —
Dietary caffeine, per 50 mg increase 0.98 (0.97 to 1.00) 0.048 0.99 (0.97 to 1.01) 0.36
Dietary saturated fat, per 5% increase 1.13 (1.05 to 1.20) <0.001 1.11 (1.03 to 1.19) 0.008
Hormone use at baseline — 0.002 — <0.001
None (referent) 1.00 — 1.00 —
Unopposed oestrogen 0.86 (0.77 to 0.97) — 1.19 (1.06 to 1.34) —
Oestrogen with progestogen 0.81 (0.71 to 0.94) — 0.85 (0.72 to 0.99) —
Statin use 1.06 (0.87 to 1.30) 0.57 0.81 (0.64 to 1.03) 0.08
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includingtheWomen’sHealthInitiativeobservational
study, have consistently shown lower cardiovascular
risk in women taking hormones, for reasons that have
been extensively discussed.
2728 Hormone use in the
currentanalysisincludesrandomisedtreatmentassign-
mentinthehormonetrials,aswellasopenlabeluseby
women not participating in those trials. Unsurpris-
ingly, the associations with cardiovascular disease
present a mixed picture.
We did not confirm the previously reported
increased predictive value of resting heart rate for
cardiovasculardeathinAfrican-Americanwomen.
9In
fact, the hazard ratio for coronary events was lower in
black, Hispanic, and Asian women than in white
women. Our models included 149 coronary events
among black women, somewhat more than the 92 in
theNationalHealthandNutritionExaminationsurvey
analysis. In addition to the difference in sample size,
disparities between ethnic groups in identification and
management of risk factors have changed since the
1970s and early 1980s when that analysis was under-
taken.
We found a stronger association between increased
heart rate and coronary events in women aged 50-64
than in those aged 65-79 (P for interaction=0.009). A
possible explanation for this finding is that chrono-
tropic insufficiency is more frequent in the older
women, reducing the reliability of heart rate as a
predictor of coronary events.
Coronary risk was consistent across the lower four
quintilesofheartrate;thehazardratioincreasedonlyin
the highest quintile. This apparent threshold poten-
tiallyincreasestheclinicalusefulnessoftheassociation;
individuals with heart rates in the highest quintile or
decile for age could be readily identified and targeted
for aggressive management of risk factors.
Conclusion
Although more elaborate, time consuming, and
expensive methods are available to assess autonomic
tone, we have found that simple measurement of
resting pulse independently predicts coronary events,
but not stroke, in postmenopausal women. The
strength of this association, from lowest to highest
quintile, is less than the association with cigarette
smoking or diabetes mellitus, but might be large
enoughtobeclinicallymeaningful,andisindependent
of physical activity.
Women’sHealthInitiativeinvestigatorsarelistedatwww.whiscience.org/
publications/WHI_investigators_shortlist.pdf.
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